Neuromodulation in Rehabilitation
How vagus nerve, magnetic and direct-current stimulation have been tested to support stroke rehabilitation, with the one FDA-approved system, the trial results and the null findings.
Content last updated . This page has not been medically reviewed.
Quick answer
In rehabilitation, brain or nerve stimulation is studied as an add-on to therapy, not as a replacement for it. The idea is that stimulation might make the nervous system more responsive to practice. That is a hypothesis. This page asks what trials measured in people after stroke: arm movement, daily activities and mood. It is information only, not medical advice. For labels, see how we label evidence.
If someone has sudden face drooping, arm weakness or slurred speech, call 911 now (United States). The UK National Health Service describes these as the main stroke symptoms and says to call emergency services at once. [1] Everything on this page applies only to recovery after the acute stage.
Technique by technique
| Technique | Status as read | Evidence | Label |
|---|---|---|---|
| Vagus nerve stimulation paired with arm therapy (implanted) | The FDA approved the Vivistim Paired VNS System on 2021-08-27 to stimulate the vagus nerve during rehabilitation to reduce upper-extremity motor deficits in chronic ischemic stroke with moderate to severe arm impairment. [2] | One pivotal randomized sham-controlled trial (108 people). [3] | Approved indication (US) |
| Repetitive magnetic stimulation (rTMS) | I did not verify any FDA clearance for stroke recovery. | Guideline-level support for some protocols, but a large sham-controlled trial found no difference. [4][5] | Mixed |
| Direct-current stimulation (tDCS) | I did not verify any FDA authorization for stroke recovery. | Meta-analyses report benefit; authors state high-quality evidence is limited. [6] | Promising but limited |
Paired vagus nerve stimulation: the details
The VNS-REHAB trial implanted a vagus nerve stimulation device in all 108 participants, who then received active or sham stimulation during 6 weeks of in-clinic therapy. [3] Arm impairment scores (Fugl-Meyer, upper extremity) rose 5.0 points with stimulation and 2.4 with sham, a between-group difference of 2.6 points (95% CI 1.0 to 4.2). [3] At 90 days, 47% of the stimulation group had a clinically meaningful response versus 24% of the sham group. [3] One surgery-related serious adverse event occurred (vocal cord paresis), in the control group. [3] The abstract names the device maker, MicroTransponder, as the funder. [3]Both groups improved, and the extra gain from stimulation was a few scale points on top of therapy. A later report followed participants for a year, but it was a post hoc, unblinded, partly crossed-over analysis, so it cannot show the added effect of stimulation. [7] The FDA approval covers one device and one indication; it does not apply to other nerve stimulators.
Magnetic stimulation (rTMS) after stroke
A European expert guideline covering literature to the end of 2018 gave its top level (definite efficacy) to low-frequency stimulation of the unaffected side of the brain for hand motor recovery in the post-acute stage, and its second level to high-frequency stimulation of the affected side. [4] Yet in a US multicenter sham-controlled trial of low-frequency rTMS over the unaffected side combined with motor training, 67% of the real group and 65% of the sham group improved at least 5 points on the arm score at 6 months, with no difference on other measures. [5] Data collection ended early, with 167 of 199 completing. [5] Both groups improved with rehabilitation. [5]Guidelines, pooled analyses and single large trials can disagree. When they do, label the evidence mixed and look at the specific protocol studied.
Direct-current stimulation (tDCS) after stroke
- A 2026 meta-analysis of 26 trials (1,038 patients) of cathodal tDCS reported better arm function and daily activities, with mild tingling and itching as the main side effects; it also said high-quality evidence on benefit, best settings and safety remains limited and that long-term durability needs checking. [6]
- A 2025 network meta-analysis of 28 studies (1,340 patients) ranked seven magnetic and direct-current protocols for arm function. [8] A ranking says which was likely best among those tested, not that any is large enough to matter to patients.
- A 2026 systematized review of 15 trials (440 participants) combining stimulation with physiotherapy found heterogeneous but generally favorable results, too varied to pool. [9]
Mood after stroke
A 2026 meta-analysis of 17 trials (917 participants) of rTMS or tDCS for post-stroke depression found larger symptom reductions than controls and no serious stimulation-related events, but the authors say certainty is limited by heterogeneity, small trials and varied protocols. [10] See neuromodulation for depression.Brain signals versus function
Trials often track brain measures, such as motor-evoked potentials from TMS. A 2026 review of 16 trials found that changes in these measures often accompanied better function, but the evidence was insufficient to show that a baseline measure predicts who responds. [11] A brain-signal change is not a recovery outcome. See clinical outcomes vs brain-signal changes.Related guides
Transcranial magnetic stimulation, tDCS and tACS research, vagus nerve stimulation and neuromodulation and cognitive research.Frequently asked questions
Can brain stimulation speed up stroke recovery?
It has been tested as an add-on to therapy. One implanted vagus nerve system has FDA approval for arm recovery in chronic stroke, with a modest gain over sham in its pivotal trial. [2][3] Magnetic and direct-current methods have mixed evidence. [5][6]
Is rTMS approved for stroke rehabilitation?
I did not verify any FDA clearance for it in the sources I read. A European expert guideline rated some protocols as effective, but a guideline is not an FDA decision. [4]
Does it replace physical therapy?
No. In the trials, stimulation was combined with therapy, and both groups improved with therapy. [3][5]
Are there risks?
Surgery risks apply to implants. [12] Non-invasive methods mainly caused tingling and itching in the tDCS review. [6]
Do home devices work the same way?
Home devices were not covered by these trials. See DIY brain stimulation risks.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
Safety and who should check first
Implanted vagus nerve stimulation involves surgery. NIMH, writing about the implanted form for depression, lists infection, pain from the implant surgery, device problems and voice changes as possible effects. [12] Non-invasive methods had mostly mild, short-lived effects in the trials above. [6] People with a seizure history, metal implants or an implanted device need medical advice first. See brain stimulation contraindications and seizure considerations and clinical vs consumer brain stimulation devices.
References
- National Health Service (UK). Symptoms of a stroke. Read 2026-10-22.
- U.S. Food and Drug Administration, openFDA device PMA record P210007 (Vivistim Paired VNS System). Read 2026-10-22.
- Dawson et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet (London, England), 2021. Read 2026-10-22.
- Lefaucheur et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clinical neurophysiology, 2020. Read 2026-10-22.
- Harvey et al. Randomized Sham-Controlled Trial of Navigated Repetitive Transcranial Magnetic Stimulation for Motor Recovery in Stroke. Stroke, 2018. Read 2026-10-22.
- Chen et al. Cathodal transcranial direct current stimulation for upper extremity functional rehabilitation in stroke survivors: a meta-analysis of parallel randomized controlled trials. Brain injury, 2026. Read 2026-10-22.
- Kimberley et al. Long-Term Outcomes of Vagus Nerve Stimulation Paired With Upper Extremity Rehabilitation After Stroke. Stroke, 2025. Read 2026-10-22.
- Zheng et al. Efficacy comparison of seven non-invasive brain stimulation techniques for upper limb motor dysfunction after stroke: a Bayesian network meta-analysis and systematic review. Frontiers in neurology, 2025. Read 2026-10-22.
- Ravichandran et al. Integrating Non-Invasive Brain Stimulation With Post-Stroke Rehabilitation: A Systematized Review of Synergistic Neuroplasticity Based Interventions. Physiotherapy research international, 2026. Read 2026-10-22.
- Huang et al. Efficacy of non-invasive brain stimulation for post-stroke depression: a systematic review and meta-analysis. Frontiers in psychology, 2026. Read 2026-10-22.
- Pereira et al. TMS-Derived Neurophysiological Measures of Corticospinal Excitability, Intracortical Excitability, and Interhemispheric Interactions Associated With Post-Stroke Motor Recovery: A Systematic Review. The European journal of neuroscience, 2026. Read 2026-10-22.
- National Institute of Mental Health. Brain Stimulation Therapies. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.